Skip to main content
. Author manuscript; available in PMC: 2021 Jul 6.
Published in final edited form as: Neurologist. 2016 Nov;21(6):112–117. doi: 10.1097/NRL.0000000000000105

TABLE 1.

Clinical and Radiographic Characteristics of Patients With Chemotherapy-associated PRES

Age (N = 70) 18–79, median: 55
Sex (%)
 Female 77
 Male 23
Blood pressure (N = 63)* 106–240/95–124, median: 170/92.5
Days until onset (N = 63) 1–60, median: 8
Duration(N = 36) 1–14, median: 4
 Fatal (%) 7
Symptoms (%)
 Seizure 64
 Altered mental status 47
 Visual changes 43
 Headache 40
 Other neurological deficit 19
 Coma 14
MRI findings (%)
 Occipital 93
 Parietal 57
 Frontal 26
 Temporal 17
*

Only case reports that included numeric measurements of presenting blood pressures were included.

Number of days between last administration of implicated chemotherapy and onset of posterior reversible encephalopathy syndrome symptoms.

Duration of symptoms was defined as number of days to significant clinical improvement.

MRI indicates magnetic resonance imaging.